
Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors …

New medicines which advance the treatment of diseases are the lifeblood of the pharmaceutical industry, and billions are invested by …
Estimates vary considerably, but many analysts put the current cost of bringing a drug to market at around $800 million, …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

